The DOI matches its Crossref record.
The capsule of Cryptococcus neoformans passively inhibits phagocytosis of the yeast by macrophages
Abstract
We examined the mechanism by which cryptococcal capsular polysaccharide inhibits phagocytosis of Cryptococcus neoformans by macrophages. O-Acetyl and carboxyl groups are major structural features of serotype D polysaccharide. Serotype D capsular polysaccharide or encapsulated whole cryptococci were de-O-acetylated by alkaline hydrolysis with 0.1 M NaOH. Carboxyl groups were reduced by treatment with 1-ethyl-3(3-dimethylaminopropyl)carbodiimide followed by reduction with sodium borohydride. De-O-acetylated or carboxyl-reduced polysaccharides had phagocytosis-inhibiting properties that did not differ appreciably from the untreated polysaccharide; thus, neither the O-acetyl nor the carboxyl groups were essential phagocytosis-inhibiting determinants. Antiserum specific for these noninhibitory groups was obtained by adsorption of cryptococcal antiserum with de-O-acetylated or carboxyl-reduced whole cells to produce antiserum enriched respectively with antibody specific for the O-acetyl and carboxyl groups. These adsorbed antisera showed opsonic activity for the untreated yeast that was similar to the unadsorbed antiserum when these antisera were compared at identical levels of precipitating antibody. We also examined the ability of Fab' fragments of opsonic IgG to reduce the amount of anticapsular IgG needed to opsonize the yeast. No synergy was noted between Fab' fragments and undigested IgG in opsonization. These results are consistent with a passive mechanism for inhibition of phagocytosis. The capsule does not directly modulate phagocytic function, but instead, presents a surface that is not recognized by the phagocyte. This absence of recognition is corrected by opsonizing antibody specific for any surface determinant on the capsule.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans
Mitchell, T. G., & Perfect, J. R. (1995) · Clinical Microbiology Reviews · doi:10.1128/cmr.8.4.515 · Cited by 1,213
Interactions of fungal pathogens with phagocytes
Erwig, L. P., & Gow, N. A. R. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2015.21 · Cited by 626
Steenbergen, J. N., Shuman, H. A., & Casadevall, A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.261418798 · Cited by 511
Heterotrimeric G Protein Signaling in Filamentous Fungi
Li, L., Wright, S. J., Krystofova, S., Park, G., & Borkovich, K. A. (2007) · Annual Review of Microbiology · doi:10.1146/annurev.micro.61.080706.093432 · Cited by 353
Encapsulation and melanin formation as indicators of virulence in Cryptococcus neoformans
Kwon-Chung, K. J., & Rhodes, J. C. (1986) · Infection and Immunity · doi:10.1128/iai.51.1.218-223.1986 · Cited by 341
Spores as Infectious Propagules of Cryptococcus neoformans
Velagapudi, R., Hsueh, Y.-P., Geunes-Boyer, S., Wright, J. R., & Heitman, J. (2009) · Infection and Immunity · doi:10.1128/iai.00542-09 · Cited by 327
What Makes Cryptococcus neoformans a Pathogen?
Buchanan, K. L., & Murphy, J. W. (1998) · Emerging Infectious Diseases · doi:10.3201/eid0401.980109 · Cited by 325
Polysaccharide antigens of the capsule of Cryptococcus neoformans
Cherniak, R., & Sundstrom, J. B. (1994) · Infection and Immunity · doi:10.1128/iai.62.5.1507-1512.1994 · Cited by 320
Expulsion of Live Pathogenic Yeast by Macrophages
Ma, H., Croudace, J. E., Lammas, D. A., & May, R. C. (2006) · Current Biology · doi:10.1016/j.cub.2006.09.032 · Cited by 310
Shoham, S., Huang, C., Chen, J.-M., Golenbock, D. T., & Levitz, S. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.7.4620 · Cited by 306
Casadevall, A., Cleare, W., Feldmesser, M., Glatman-Freedman, A., Goldman, D. L., Kozel, T. R., Lendvai, N., Mukherjee, J., Pirofski, L.-A., Rivera, J., et al. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.6.1437 · Cited by 298
Self-citationVirulence factors of medically important fungi
Hogan, L. H., Klein, B. S., & Levitz, S. M. (1996) · Clinical Microbiology Reviews · doi:10.1128/cmr.9.4.469 · Cited by 271
Basic principles of the virulence of Cryptococcus
Zaragoza, O. (2019) · Virulence · doi:10.1080/21505594.2019.1614383 · Cited by 249
Larsen, R. A., Pappas, P. G., Perfect, J., Aberg, J. A., Casadevall, A., Cloud, G. A., James, R., Filler, S., & Dismukes, W. E. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.3.952-958.2005 · Cited by 236
Nosanchuk, J. D., & Casadevall, A. (1997) · Infection and Immunity · doi:10.1128/iai.65.5.1836-1841.1997 · Cited by 170
Kozel, T. R., Highison, B., & Stratton, C. J. (1984) · Infection and Immunity · doi:10.1128/iai.43.2.574-579.1984 · Cited by 95
Self-citationStie, J., Bruni, G., & Fox, D. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005780 · Cited by 85
Ibrahim, A. S., Filler, S. G., Alcouloumre, M. S., Kozel, T. R., Edwards, J. E., & Ghannoum, M. A. (1995) · Infection and Immunity · doi:10.1128/iai.63.11.4368-4374.1995 · Cited by 83
Self-citationStie, J., & Fox, D. (2012) · Microbiology · doi:10.1099/mic.0.051524-0 · Cited by 55
Na Pombejra, S., Salemi, M., Phinney, B. S., & Gelli, A. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00296 · Cited by 47
Dragotakes, Q., Fu, M. S., & Casadevall, A. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1801118 · Cited by 39
Metadata
- Authors
- Kozel, T. R., & Gotschlich, E. C.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1983-04-01
- Volume
- 130
- Issue
- 4
- Pages
- 1994-1994
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1567581543
- Cited by
- 239
- References
- 0
- FWCI
- 5.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.